Colchicine and gout
1991; Wiley; Volume: 34; Issue: 6 Linguagem: Inglês
10.1002/art.1780340622
ISSN1529-0131
AutoresLarry W. Moreland, Gene V. Ball,
Tópico(s)Autoimmune and Inflammatory Disorders Research
ResumoArthritis & RheumatismVolume 34, Issue 6 p. 782-786 EditorialFree to Read Colchicine and gout Larry W. Moreland MD, Corresponding Author Larry W. Moreland MD Instructor in Medicine Division of Clinical Immunology and Rheumatology, The University of Alabama at BirminghamDivision of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, 602 Medical Education Building. Birmingham, AL 35294Search for more papers by this authorGene V. Ball MD, Gene V. Ball MD Professor of Medicine Division of Clinical Immunology and Rheumatology, The University of Alabama at BirminghamSearch for more papers by this author Larry W. Moreland MD, Corresponding Author Larry W. Moreland MD Instructor in Medicine Division of Clinical Immunology and Rheumatology, The University of Alabama at BirminghamDivision of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, 602 Medical Education Building. Birmingham, AL 35294Search for more papers by this authorGene V. Ball MD, Gene V. Ball MD Professor of Medicine Division of Clinical Immunology and Rheumatology, The University of Alabama at BirminghamSearch for more papers by this author First published: June 1991 https://doi.org/10.1002/art.1780340622Citations: 17AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Kelley WN, Fox IH: Gout and related disorders of purine metabolism, Textbook of Rheumatology. Second edition. Edited by WN Kelley, ED Harris, S Ruddy, CB Sledge. Philadelphia, WB Saunders, 1985 Google Scholar 2 Kelley WN, Fox IH, Palella TD: Gout and related disorders of purine metabolism, Textbook of Rheumatology. Third edition. Edited by WN Kelley, ED Harris, S Ruddy, CB Sledge. Philadelphia, WB Saunders, 1989 Google Scholar 3 Roberts WN, Liang MH, Stern SH: Colchicine in acute gout: reassessment of risks and benefits. JAMA 257: 1920–1922, 1987 10.1001/jama.1987.03390140090033 CASPubMedWeb of Science®Google Scholar 4 Freeman DL: Frequent doses of intravenous colchicine can be lethal. N Engl J Med 309: 310, 1983 10.1056/NEJM198308043090512 CASPubMedWeb of Science®Google Scholar 5 Stanley MW, Taurog JD, Snover DC: Fatal colchicine toxicity: report of a case. Clin Exp Rheumatol 2: 167–171, 1984 PubMedWeb of Science®Google Scholar 6 Ferrannini E, Pentimone F: Marrow asplasia following colchicine treatment for gouty arthritis. Clin Exp Rheumatol 2: 173–175, 1984 CASPubMedWeb of Science®Google Scholar 7 Terkeltaub RA, Ginsberg MH, McCarty DJ: Pathogenesis and treatment of crystal-induced inflammation, Arthritis and Allied Conditions. Eleventh edition. Edited by DJ McCarty. Philadelphia, Lea & Febiger, 1989 Google Scholar 8 Ahern MJ, Reid C, Gordon TP, McCredie M, Brooks PM, Jones M: Does colchicine work? Results of the first controlled study in gout. Aust N Z J Med 17: 301–304, 1987 10.1111/j.1445-5994.1987.tb01232.x CASPubMedWeb of Science®Google Scholar 9 Goldfinger SE: The treatment of gout. N Engl J Med 285: 1303–1306, 1971 10.1056/NEJM197112022852306 CASPubMedWeb of Science®Google Scholar 10 Emmerson BT: The management of gout. Med J Aust 1: 475–478, 1972 10.5694/j.1326-5377.1972.tb46879.x CASPubMedWeb of Science®Google Scholar 11 Wallace SL: The treatment of gout. Arthritis Rheum 15: 317–323, 1972 10.1002/art.1780150316 CASPubMedWeb of Science®Google Scholar 12 Gutman AB: Medical management of gout. Postgrad Med 51: 61–66, 1972 CASPubMedWeb of Science®Google Scholar 13 Wallace SL, Bernstein D, Diamond H: Diagnostic value of the colchicine therapeutic trial. JAMA 199: 93–96, 1967 PubMedGoogle Scholar 14 Davis JS, Bartfeld H: The effect of intravenous colchicine on acute gout. Am J Med 16: 218–219, 1954 10.1016/0002-9343(54)90337-X PubMedWeb of Science®Google Scholar 15 Davis JS: Safety and effectiveness of colchicine by intravenous administration in the treatment of gout. J Clin Pharmacol 9: 410–412, 1969 10.1177/009127006900900610 CASWeb of Science®Google Scholar 16 Carmichael LP: Treatment of acute gout with injection of colchicine. JAMA 170: 1410–1411, 1959 10.1001/jama.1959.63010120002013a CASPubMedWeb of Science®Google Scholar 17 Seegmiller JE: The present-day treatment of gout. Med Clin North Am 45: 1259–1272, 1961 10.1016/S0025-7125(16)33833-0 CASPubMedWeb of Science®Google Scholar 18 Graham W, Robert JB: Intravenous colchicine in the management of gouty arthritis. Ann Rheum Dis 12: 16–19, 1983 10.1136/ard.12.1.16 Web of Science®Google Scholar 19 Hammond BV, Luciani I: Case review: fatal IV colchicine injection in a 60 year old woman. J Emerg Nurs 15: 80–82, 1989 PubMedGoogle Scholar 20 Wallace SL, Singer JZ: Review: systemic toxicity associated with the intravenous administration of colchicine—guidelines for use. J Rheumatol 15: 495–499, 1988 CASPubMedWeb of Science®Google Scholar 21 Stemmermann GN, Hayashi T: Colchicine intoxication: a reappraisal of its pathology based on a study of three fatal cases. Hum Pathol 2: 321–332, 1971 10.1016/S0046-8177(71)80040-0 PubMedWeb of Science®Google Scholar 22 Boruchow IB: Bone marrow depression associated with acute colchicine toxicity in the presence of hepatic dysfunction. Cancer 19: 541–543, 1966 10.1002/1097-0142(196604)19:4 3.0.CO;2-Y CASPubMedWeb of Science®Google Scholar 23 Carr AA: Colchicine toxicity. Arch Intern Med 115: 29–55, 1965 10.1001/archinte.1965.03860130031005 CASPubMedWeb of Science®Google Scholar 24 Kuncl RW, Duncan G, Watson D, Alderson K, Rogawski MA, Peper M: Colchicine myopathy and neuropathy. N Engl J Med 316: 1562–1568, 1987 10.1056/NEJM198706183162502 CASPubMedWeb of Science®Google Scholar 25 Simons RJ, Kingma DW: Fatal colchicine toxicity. Am J Med 86: 356–357, 1989 10.1016/0002-9343(89)90315-X PubMedWeb of Science®Google Scholar 26 Wells SR, Anderson DL, Thompson J: Colchicine toxicity: a case report. Vet Hum Toxicol 31: 313–316, 1989 CASPubMedWeb of Science®Google Scholar 27 Liu YK, Hymowitz R, Carroll MG: Marrow aplasia induced by colchicine: a case report. Arthritis Rheum 21: 731–735, 1978 10.1002/art.1780210622 CASPubMedWeb of Science®Google Scholar 28 Reginato AJ, Schumaher HR Jr: Crystal-associated arthropathies. Clin Geriatr Med 2: 295–322, 1988 Google Scholar 29 Paulus HE, Schlosstein LH, Godfrey RG, Klinenberg JR, Bluestone R: Prophylactic colchicine therapy of intercritical gout: a placebo-controlled study of probenecid-treated patients. Arthritis Rheum 17: 609–614, 1974 10.1002/art.1780170517 CASPubMedWeb of Science®Google Scholar 30 Neuss MN, McCallum RM, Brenckman WD, Silberman HR: Long-term colchicine administration leading to colchicine toxicity and death. Arthritis Rheum 29: 448–449, 1986 10.1002/art.1780290324 PubMedWeb of Science®Google Scholar 31 Kontos HAL: Myopathy associated with chronic colchicine toxicity. N Engl J Med 266: 38–39, 1962 10.1056/NEJM196201042660111 PubMedWeb of Science®Google Scholar 32 Riggs JE, Schochet SS Jr, Gutmann L, Crosby TW, DiBartolomeo AG: Chronic human colchicine neuropathy and myopathy. Arch Neurol 43: 521–523, 1986 10.1001/archneur.1986.00520050091033 PubMedWeb of Science®Google Scholar 33 Dinarello CA, Wolff SM, Goldfinger SE, Dae DC, Alling DW: Colchicine therapy for familial Mediterranean fever. N Engl J Med 291: 934–937, 1974 10.1056/NEJM197410312911804 CASPubMedWeb of Science®Google Scholar 34 Dinarello CA, Chusid MJ, Fauci AS, Gallin JI, Dale DC, Wolff SM: Effect of prophylactic colchicine therapy on leukocyte function in patients with familial Mediterranean fever. Arthritis Rheum 19: 618–622, 1976 10.1002/art.1780190315 CASPubMedWeb of Science®Google Scholar 35 Ehrenfeld M, Brzezinski A, Levy M, Eliakim M: Fertility and obstetric history in patients with familial Mediterranean fever on long-term colchicine therapy. Br J Obstet Gynecol 94: 1186–1191, 1987 10.1111/j.1471-0528.1987.tb02320.x CASPubMedWeb of Science®Google Scholar 36 Ehrenfeld M, Levy M, Margaliothe J, Eliakim M: The effects of long-term colchicine therapy on male fertility in patients with familial Mediterranean fever. Andrologia 18: 420–426, 1986 10.1111/j.1439-0272.1986.tb01801.x CASPubMedWeb of Science®Google Scholar 37 Ehrenfeld M, Levy M, Sharon P, Rachmilawitz D, Eliakim M: Gastrointestinal effects of long-term colchicine therapy in patients with recurrent polyserositis (familial Mediterranean fever). Dig Dis Sci 27: 723–727, 1982 10.1007/BF01393768 CASPubMedWeb of Science®Google Scholar 38 Goldstein RC, Schwabb AD: Prophylactic colchicine therapy in familial Mediterranean fever, a controlled double-blind study. Ann Intern Med 81: 792–794, 1974 10.7326/0003-4819-81-6-792 CASPubMedWeb of Science®Google Scholar 39 Lehman TJA, Peters RS, Hanson V, Schwabe AD: Long-term colchicine therapy of familial Mediterranean fever by colchicine. Clin Exp Immunol 46: 77–81, 1981 PubMedWeb of Science®Google Scholar 40 Levy M, Yaffe C: Testicular function in patients with familial Mediterranean fever on long-term colchicine treatment. Fertil Steril 29: 667–668, 1978 10.1016/S0015-0282(16)43342-X CASPubMedWeb of Science®Google Scholar 41 Milano AM: Familial Mediterranean fever associated with menstruation: efficacy of intermittent colchicine therapy. Am J Gastroenterol 76: 363–364, 1981 CASPubMedWeb of Science®Google Scholar 42 Wright DG, Wolff SM, Fauci AS, Alling DW: Efficacy of intermittent colchicine therapy in familial Mediterranean fever. Ann Intern Med 86: 162–165, 1977 10.7326/0003-4819-86-2-162 CASPubMedWeb of Science®Google Scholar 43 Zemer D, Pras M, Sohar E, Gafni J: Colchicine in familial Mediterranean fever. N Engl J Med 294: 170–171, 1976 10.1056/NEJM197601152940327 CASPubMedWeb of Science®Google Scholar 44 Zemer D, Ravach M, Pras M, Modan B, Schor S, Sohar E, Gafni J: A controlled trial of colchicine in preventing attacks of familial Mediterranean fever. N Engl J Med 291: 932–934, 1974 10.1056/NEJM197410312911803 CASPubMedWeb of Science®Google Scholar 45 Zemer D, Pras M, Sohar E, Modan M, Cabilli S, Gafni J: Colchicine in the prevention and treatment of amyloidosis of familial Mediterranean fever. N Engl J Med 314: 1001–1005, 1986 10.1056/NEJM198604173141601 CASPubMedWeb of Science®Google Scholar 46 Merlin HE: Azoospermia caused by colchicine: a case report. Fertil Steril 23: 180–181, 1972 10.1016/S0015-0282(16)38823-9 CASPubMedWeb of Science®Google Scholar 47 Bremner WJ, Paulsen ZA: Colchicine and testicular function in men. N Engl J Med 294: 1384, 1976 10.1056/NEJM197606172942508 CASPubMedWeb of Science®Google Scholar 48 Kaplan MM, Alling DW, Zimmerman HJ: A prospective trial of colchicine for primary biliary cirrhosis. N Engl J Med 315: 1448–1454, 1986 10.1056/NEJM198612043152304 CASPubMedWeb of Science®Google Scholar 49 Bodenheimer H Jr, Schaffner F, Pezzullo J: Evaluation of colchicine therapy in primary biliary cirrhosis. Gastroenterology 95: 124–129, 1988 10.1016/0016-5085(88)90300-9 PubMedWeb of Science®Google Scholar 50 Malawista SE: Colchicine: a common mechanism for its anti-inflammatory and anti-mitotic effects. Arthritis Rheum 11: 191–197, 1968 10.1002/art.1780110210 CASPubMedWeb of Science®Google Scholar 51 Ertel NH, Wallace SL: Measurement of colchicine in urine and peripheral leukocytes (abstract). Clin Res 19: 348, 1971 Google Scholar 52 Phelps P: Polymorphonucler leukocyte motility in vitro. IV. Colchicine inhibition of chemotactic activity formation after phagocytosis of urate crystals. Arthritis Rheum 13: 1–9, 1970 10.1002/art.1780130101 CASPubMedWeb of Science®Google Scholar 53 Pesanti EL, Axline SG: Colchicine effects on lysosomal enzyme induction and intracellular degradation in the cultivated macrophage. J Exp Med 141: 1030–1046, 1975 10.1084/jem.141.5.1030 CASPubMedWeb of Science®Google Scholar 54 Wallace ST: Colchicine. Semin Arthritis Rheum 3: 369–381, 1974 10.1016/0049-0172(74)90006-7 CASPubMedGoogle Scholar 55 Saunder PH, Kopferschmitt J, Jaeger A, Mountz JM: Haemodynamic studies in eight cases of acute colchicine poisoning. Hum Toxicol 2: 169–173, 1983 10.1177/096032718300200201 PubMedWeb of Science®Google Scholar 56 Mendis S: Colchicine cardiotoxicity following ingestion of Gloriosa superba tubers. Postgrad Med J 65: 752–755, 1989 10.1136/pgmj.65.768.752 CASPubMedWeb of Science®Google Scholar 57 Goldschmidt RB, Steward O: Comparison on neurotoxic effects of colchicine, the vinca alkaloids, and other microtubule poisons. Brain Res 486: 133–140, 1989 10.1016/0006-8993(89)91285-7 CASPubMedWeb of Science®Google Scholar 58 Seubert P, Nakagawa Y, Ivy G, Vanderklish P, Baudry M, Lynch G: Introhippocampal colchicine injection results in spectrin proteolysis. Neuroscience 31: 195–202, 1989 10.1016/0306-4522(89)90041-9 CASPubMedWeb of Science®Google Scholar 59 Stapzynski JS, Rothstein RJ, Gaye WA, Niemann JT: Colchicine overdose: report of two cases and review of the literature. Ann Emerg Med 10: 364–369, 1981 10.1016/S0196-0644(81)80239-9 PubMedWeb of Science®Google Scholar 60 Baum J, Meyerowitz S: Colchicine: its use as a suicidal drug by females. J Rheumatol 7: 124–127, 1980 CASPubMedWeb of Science®Google Scholar 61 Wallace SL, Singer JZ: Therapy in gout. Rheum Dis Clin North Am 14: 441–457, 1988 10.1016/S0889-857X(21)00975-3 CASPubMedWeb of Science®Google Scholar 62 Altman RD, Honig S, Levin JM, Lightfoot RW: Ketoprofen versus indomethacin in patients with acute gouty arthritis: a multicenter double blind comparative study. J Rheumatol 15: 1422–1426, 1988 CASPubMedWeb of Science®Google Scholar 63 Hart FD, Boardman PL: Indomethacin: a new nonsteroid anti-inflammatory agent. Br Med J 2: 965–970, 1963 10.1136/bmj.2.5363.965 CASPubMedGoogle Scholar 64 Sturge RA, Scott JT, Hamilton EBD, Liyanage SP, Dixon ASJ, Davies J, Engler C: Multicentre trial of naproxen and phenylbutazone in acute gout. Ann Rheum Dis 36: 80–82, 1977 10.1136/ard.36.1.80 CASPubMedWeb of Science®Google Scholar 65 Schwitz MC, Nashel DJ, Alepa P: Ibuprofen in the treatment of acute gouty arthritis. JAMA 239: 34–35, 1978 10.1001/jama.239.1.34 PubMedWeb of Science®Google Scholar 66 Wanasukapunt S, Lertratanakul Y, Rubinstein HM: Effect of fenoprofen calcium on acute gouty arthritis. Arthritis Rheum 19: 933–935, 1976 10.1002/art.1780190516 CASPubMedWeb of Science®Google Scholar 67 Bluestone RH: Safety and efficacy of piroxicam in the treatment of gout. Am J Med 72: 66–69, 1982 Google Scholar 68 Brogden RN, Heel RC, Spight TM, Avery GS: Sulindac, a review of its pharmacological properties and therapeutic efficacy in rheumatic diseases. Drugs 16: 97–114, 1978 10.2165/00003495-197816020-00001 CASPubMedWeb of Science®Google Scholar 69 Kuzell WC, Schaffrazick RW, Brown B, Mankle EA: Phenylbutazone (Butazolidin) in rheumatoid arthritis and gout. JAMA 149: 729–734, 1952 10.1001/jama.1952.02930250011004 CASPubMedWeb of Science®Google Scholar 70 Mauer EF: The toxic effects of phenylbutazone (Butazolidin). N Engl J Med 253: 404–410, 1955 10.1056/NEJM195509082531003 CASPubMedWeb of Science®Google Scholar 71 Tamisier JN: Ketoprofen. Clin Rheum Dis 5: 381–391, 1979 Web of Science®Google Scholar 72 Petera P, Gainmayer K, Tausch G: Treatment of acute gout with tolmetin. Wien Med Wochenschr 132: 43–45, 1982 CASPubMedWeb of Science®Google Scholar 73 Willkens RF, Case JB: Treatment of acute gout with naproxen. Scand J Rheumatol Suppl 2: 69–71, 1973 Google Scholar 74 O'Brien WM: Indomethacin: a survey of clinical trials. Med Pharmacol Ther 9: 94–107, 1967 Google Scholar Citing Literature Volume34, Issue6June 1991Pages 782-786 ReferencesRelatedInformation
Referência(s)